August 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountcybersight.org
Global Rank
#403,570
3,821Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
37.68%
Pages per Visit
2.90
Avg Visit Duration
00:00:54
- Company
- - -
- Industry
- - -
Top 10 cybersight.org Competitors
The Top 10 Sites Like cybersight.org in August 2026 are ranked by their affinity to cybersight.org in terms of keyword traffic, audience targeting, and market overlap
Objective To evaluate the literature-pooled functional, anatomical and safety outcomes of aflibercept biosimilars compared with reference aflibercept for neovascular age-related macular degeneration (nAMD).Methods and analysis Systematic review and meta-analysis. Medline, Embase and CENTRAL were searched from inception to 2 June 2025. Phase 3 randomised controlled trials (RCTs) comparing aflibercept biosimilars with the reference product in patients with nAMD were included. Two independent reviewers conducted screening, data extraction, risk of bias (RoB 2) assessment and certainty of evidence assessment (Grading of Recommendations, Assessment, Development and Evaluation), with a third reviewer resolving discrepancies. Primary outcomes included mean difference (MD) change in best-corrected visual acuity (BCVA) and retinal thickness over time, risk ratio (RR) for proportion of participants gaining >15 Early Treatment Diabetic Retinopathy Study (ETDRS) letters and RR for adverse events. Meta-regression was used to evaluate the temporal stability of continuous outcomes.Results Six RCTs involving 2044 participants (1026 biosimilar, 1018 reference) were included. Five aflibercept biosimilars were evaluated, representing more than 50% of the eight biosimilars currently approved worldwide. Meta-regression revealed no significant difference in MD change in BCVA over time between biosimilar and reference aflibercept (slope: 0.0321 letters/week; p=0.1013). For MD change in retinal thickness, an initial anatomical advantage for reference aflibercept at week 0 (intercept: 9.58 µm; p=0.0449) was not sustained over time (slope: –0.1685 µm/week; p=0.2303). The pooled RR for gaining >15 ETDRS letters from baseline was 1.19 (95% CI 0.98 to 1.45; p=0.079). No statistically significant differences were observed across 15 safety outcomes.Conclusion This systematic review and meta-analysis found no statistically significant differences in functional, anatomical or safety outcomes betwee
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
68.62%
Pages per Visit
1.75
Avg Visit Duration
00:00:52
Similarity Score
100%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
35.13%
Pages per Visit
3.22
Avg Visit Duration
00:00:44
Similarity Score
97%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
58.32%
Pages per Visit
2.99
Avg Visit Duration
00:01:46
Similarity Score
95%Medvarsity is Asia`s largest healthcare EdTech company accredited by BAC.We provide 200+ blended learning medical fellowship and certificate courses for medical professionals.
- Company
- Medvarsity Online
- Industry
- Health
Bounce Rate
47.1%
Pages per Visit
2.45
Avg Visit Duration
00:01:38
Similarity Score
88%Struggling student veterinary nurses need empathy, structure, and timely support. Learn how to spot early signs, start compassionate conversations, and access guidance to help SVNs get back on track and thrive in practice.
Global Rank
#539,636
168,587Bounce Rate
49.88%
Pages per Visit
5.60
Avg Visit Duration
00:02:05
Similarity Score
86%award winning customer service software, trusted by 200,000+ customers. make your customers happy via text, mobile, phone, email, live chat, social media.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
58.12%
Pages per Visit
2.45
Avg Visit Duration
00:01:34
Similarity Score
83%IBC International Business Consult offers medical training & certification programs in Dubai. Our certificate courses in medical are internationally recognized.
- Company
- - -
- Industry
- - -
Global Rank
#2,216,053
435,882Bounce Rate
41.91%
Pages per Visit
1.85
Avg Visit Duration
00:00:36
Similarity Score
78%A CCRN certification course can increase your chances of passing the exam by providing intensive, focused study on exam content and test-taking strategies.
- Company
- - -
- Industry
- - -
Bounce Rate
32.89%
Pages per Visit
4.26
Avg Visit Duration
00:14:03
Similarity Score
73%Many people are still showing up to work, but they are no longer emotionally present. Emotional disconnection leads to reduced empathy, engagement, and connection. Humans are wired for belonging. When that need is unmet, the brain shifts into withdrawal and detachment. This, in turn, is protection and not failure. Burnout begins with disconnection, not exhaustion.
- Company
- - -
- Industry
- - -
Global Rank
#847,690
439,203Bounce Rate
43.48%
Pages per Visit
2.00
Avg Visit Duration
00:01:28
Similarity Score
72%- Company
- - -
- Industry
- - -
Global Rank
#782,124
318,101Bounce Rate
13.92%
Pages per Visit
16.08
Avg Visit Duration
00:28:46
Similarity Score
71%cybersight.org's top 5 competitors in August 2026 are: bmjophth.bmj.com, public.jaeb.org, ophthalmology.hku.hk, medvarsity.com, and more.
According to Similarweb data of monthly visits, cybersight.org’s top competitor in August 2026 is bmjophth.bmj.com. cybersight.org 2nd most similar site is public.jaeb.org, and closing off the top 3 is ophthalmology.hku.hk.
medvarsity.com ranks as the 4th most similar website to cybersight.org and caw.ac.uk ranks fifth in August 2026.
The other five competitors in the top 10 list are ptcb.zendesk.com, ibcme.com, ccrnacademy.com, sweetinstitute.com, and dermqbank.com.